Endometrial cancer
EJ Crosbie, SJ Kitson, JN McAlpine, A Mukhopadhyay… - The Lancet, 2022 - thelancet.com
Endometrial cancer is the most common gynaecological cancer in high income countries
and its incidence is rising globally. Although an ageing population and fewer benign …
and its incidence is rising globally. Although an ageing population and fewer benign …
Current and emerging prognostic biomarkers in endometrial cancer
K Njoku, CE Barr, EJ Crosbie - Frontiers in Oncology, 2022 - frontiersin.org
Endometrial cancer is the most common gynaecological malignancy in high income
countries and its incidence is rising. Whilst most women with endometrial cancer are …
countries and its incidence is rising. Whilst most women with endometrial cancer are …
Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society
This care pathway from the European Menopause and Andropause Society (EMAS)
provides an updated pathway for monitoring and guidance of women at midlife, focusing on …
provides an updated pathway for monitoring and guidance of women at midlife, focusing on …
Current approaches to the management of patients with endometrial cancer
E Kalampokas, G Giannis, T Kalampokas… - Cancers, 2022 - mdpi.com
Simple Summary New data, the development of new methods of treatment and management
and the rising incidence of endometrial cancer require constant reviewing, in order to inform …
and the rising incidence of endometrial cancer require constant reviewing, in order to inform …
Efficacy and safety of PD-1/PD-L1 inhibitor as single-agent immunotherapy in endometrial cancer: a systematic review and meta-analysis
Simple Summary The programmed cell death protein 1 (PD-1)/programmed cell death
ligand 1 (PD-L1) pathway controls the induction and maintenance of immune tolerance …
ligand 1 (PD-L1) pathway controls the induction and maintenance of immune tolerance …
Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A …
K Njoku, CE Barr, NC Ramchander, EJ Crosbie - PloS one, 2022 - journals.plos.org
Purpose The Onodera's prognostic nutritional index (PNI) and the haemoglobin, albumin,
lymphocyte and platelet (HALP) score are immune-nutritional indices that correlate with …
lymphocyte and platelet (HALP) score are immune-nutritional indices that correlate with …
Expression of PD-1 and PD-L1 in endometrial cancer: molecular and clinical significance
The landscape of diagnosing and treating endometrial cancer is undergoing a profound
transformation due to the integration of molecular analysis and innovative therapeutic …
transformation due to the integration of molecular analysis and innovative therapeutic …
[HTML][HTML] Gynecological malignancies and obesity
HJ Agnew, SJ Kitson, EJ Crosbie - Best Practice & Research Clinical …, 2023 - Elsevier
The global pandemic of obesity has had a significant impact on gynecological malignancies,
most notably endometrial cancer. It has resulted in worldwide increases in the incidence of …
most notably endometrial cancer. It has resulted in worldwide increases in the incidence of …
Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women
Background A non-invasive endometrial cancer detection tool that can accurately triage
symptomatic women for definitive testing would improve patient care. Urine is an attractive …
symptomatic women for definitive testing would improve patient care. Urine is an attractive …
Impact of type 2 diabetes mellitus on endometrial cancer survival: a prospective database analysis
K Njoku, HJ Agnew, EJ Crosbie - Frontiers in Oncology, 2022 - frontiersin.org
Purpose Type 2 diabetes mellitus (T2DM) is an established risk factor for endometrial cancer
but its impact on endometrial cancer survival outcomes is unclear. The aim of this study was …
but its impact on endometrial cancer survival outcomes is unclear. The aim of this study was …